Checklist to Prepare Physician Offices for COVID-19
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Definition of a Person Under Investigation (PUI)
Definition of a Person Under Investigation (PUI) Epidemiologic Risk (Exposure) & Clinical Features Close contact^ with a person that has laboratory-confirmed Asymptomatic§ COVID-19 OR Developed one or more of the following symptoms within 14 days of last exposure: • fever* • chills • rigors • myalgia Travel to locations on the KDHE Travel Related Quarantine Table • malaise https://www.coronavirus.kdheks.gov/175/Travel-Exposure-Related- and • headache Isolation-Quaran • sore throat • lower respiratory illness (cough, shortness of breath, or difficulty breathing) • new olfactory and taste disorders • congestion or runny nose • nausea or vomiting • diarrhea without an alternate more likely diagnosis. One or more of the following symptoms: • fever* and • chills • rigors No source of exposure has been identified • myalgia • malaise • headache • sore throat • lower respiratory illness (cough, shortness of breath, or difficulty breathing) 1 | Page • new olfactory and taste disorders • congestion or runny nose • nausea or vomiting • diarrhea without an alternate more likely diagnosis. ^ You are a "close contact" if any of the following situations happened while you spent time with a person with COVID-19, even if they didn't have symptoms: • Were within 6 feet of the person for 10 consecutive minutes or more • Had contact with the person's respiratory secretions (for example, coughed or sneezed on; kissed; contact with a dirty tissue; shared a drinking glass, food, towels, or other personal items) • Live with the person or stayed overnight for at least one night in a house with the person. The chance of spreading the virus is greater the longer an infected person or persons are close to someone. -
Strategies to Increase Health Facility Deliveries: Three Case Studies
Strategies to increase health facility deliveries: Three case studies Strategies to increase health facility deliveries: Three case studies Copyright © 2014 UCSF Global Health Group The Global Health Group Global Health Sciences University of California, San Francisco 550 16th Street, 3rd Floor San Francisco, CA 94158 USA Email: [email protected] Website: globalhealthsciences.ucsf.edu/global-health-group Ordering information This publication is available for electronic download at globalhealthsciences.ucsf.edu/global-health-group/ ghg-publications Recommended citation Butrick, E., Diamond-Smith, N., Beyeler, N., Montagu, D., Sudhinaraset, M. (2014). Strategies to increase health facility deliveries: Three case studies. Global Health Group, Global Health Sciences, University of California, San Francisco. Cover photos courtesy of Photoshare. © 2006 Abhijit Dey (India) and © 2012 Akintunde Akinleye/NURHI (Nigeria). Produced in the United States of America. First Edition, December 2014 This is an open-access document distributed under the terms of the Creative Commons Attribution-Noncommercial License, which permits any noncommercial use, distribution, and repro- duction in any medium, provided the original authors and source are credited. Contents Introduction | 1 Methods | 2 Country selection process | 2 Interviews and recruitment | 2 Description of each case study | 3 Malawi | 3 Nigeria | 3 India | 3 Summary of themes | 4 Lesson learned #1: Political will | 4 Lesson learned #2: Balancing supply, demand and quality | 5 Lesson learned -
Hospice and COVID-19
Hospice and COVID-19 For a profession whose mission is to help terminally ill patients plan their final days and guide them and their loved ones through the passage emotionally and spiritually, a global pandemic presented the ultimate challenge. ASPR TRACIE met with Sarah McSpadden, RN, MSN, MHA, President and Chief Executive Officer of The Elizabeth Hospice, to learn more about her experiences during the COVID-19 pandemic. HIGHLIGHT ASPR TRACIE Sarah, can you please tell us more about your work and the clients Related Resources you serve? COVID-19 Home-based Healthcare Sarah McSpadden (SM) and Hospice Resource Collection Our mission is to enhance the lives of those nearing the end of Engagement of Home Health life’s journey and to care for those who grieve. As a community- and Hospice Agencies in Medical based organization, we ensure that hospice care, palliative care, Surge Activities and bereavement support are available for all who face advanced Homecare and Hospice Topic serious illness. Our Elizabeth Supportive Medical Specialists provide Collection personalized medical care for adults and children who need palliative support. The Elizabeth Hospice is one of the few organizations across Medical Surge and the Role of the nation with a dedicated team specializing in perinatal and pediatric Home Health and Hospice Agencies hospice. Our comprehensive grief support program serves families from (Full Report) the community no matter how their person died or whether their person Hospice and Emergency was on service with us. Preparedness: Experiences from We were founded in 1978 when hospice was an all-volunteer program. the Field In 1982, there was a significant shift: hospice became Medicare- reimbursable and we could hire permanent staff. -
Guidelines for Pharmacists and the Pharmacy Workforce
UPDATED 14 JULY 2020 FIP HEALTH ADVISORY COVID-19: GUIDELINES FOR PHARMACISTS AND THE PHARMACY WORKFORCE INTERNATIONAL PHARMACEUTICAL FEDERATION COVID-19: GUIDELINES FOR PHARMACISTS AND THE PHARMACY WORKFORCE FIP will update this interim guidance as more information becomes available. Table of contents Purpose of this document 2 Responsibilities and role of community pharmacy 2 Responsibilities and role of hospital pharmacy 4 Pharmacy activities 5 Pharmacy staff 5 Pharmacy operations and facilities: ensuring safety and continuity of service 5 Preventive measures 8 Use of masks: Recommendations for pharmacy staff and the public 9 Advice to the community 14 Recommendation for outpatient care 14 Patient isolation and referral 15 Home care for patients with suspected COVID-19 presenting with mild symptoms 15 Diagnostic testing for COVID-19 in suspected human cases 15 Ensuring stock and access to key medicines, equipment and facilities 17 Cleaning and disinfection management 17 Infection control: other precautions 18 Infection control: hand washing and hand rubbing 19 How to prepare alcohol-based handrub formulations 19 Pharmacy as an information resource 19 Addressing travel concerns 20 Bibliography 21 ANNEX 1: List of key facilities, equipment, and personal protective equipment using during COVID-19 infections 24 ANNEX 2: Viability of SARS-CoV-2 in aerosols and on different surfaces, and list of disinfectants for commonly contaminated objects 25 ANNEX 3: WHO guide to local production of handrub formulations 26 Validity 29 Acknowledgements 29 COVID-19 pandemic: Guidelines for pharmacists and the pharmacy workforce | Page 1 of 29 Purpose of this Since December 2019, an outbreak of a new human coronavirus has spread to many document countries, causing millions of cases and hundreds of thousands of deaths. -
Barrier Isolation Technology: a Labor-Efficient Alternative to Cleanrooms
Barrier Isolation Technology: A Labor-Efficient Alternative To Cleanrooms Paul Mosko, MS. FASHP and Hank Rahe, BSIM, MSE Abstract - Barrier isolation technology has been recognized by the Food and Drug Administration for a number of years as a sage and effective way to process parenteral products aseptically. Pharmaceutical companies have shown that this method of processing increases the sterility assurance level of their products and reduces manufacturing costs. Hospital pharmacies in Europe have used this technology for more than 10 years as a means of product and personnel protection. In the United States, the technology is becoming accepted because of its capital cost effectiveness and because it increases safety during the preparation of cytotoxic compounds. Some pharmacists, however, have expressed concerns about the efficiency of such systems in the pharmacy setting. Using work measurement techniques, the authors tested a barrier isolator system at the University of Cincinnati Hospital. The results are presented here. Key Words - barrier/isolator technology: cleanrooms: parenteral drugs Hosp Pharm - 1999:34:834-838 Providing a facility for the manipulation of parenteral drugs within the pharmacy is a significant concern for health care organizations because of the costs, space requirements, and potential lack of flexibility this preparation often entails. The American Society of Health-System Pharmacists (ASHP) has focused on quality working conditions in health system pharmacies by upgrading the guidelines for cleanliness in prepatory work environments. (1) Some have interpreted these guidelines simply to mean laminar flow hoods or "cleanrooms," because these have been the conventional particulate-control technology for more than 40 years. (2) Some states have taken steps to upgrade the quality of the environment in which IV admixtures and cytotoxic compounds are prepared recognizing new technologies that can achieve this goal. -
Note on Health Facility and Types Larina Brooklyn * College of Medicine and Health Academy, Nigeria
Health Econ Outcome Res Open Access 2021, Vol.7, Issue 5, e114. Editorial Note on Health Facility and Types Larina Brooklyn * College of Medicine and Health Academy, Nigeria Corresponding Author* clinics are these days staffed by expertly prepared specialists, attendants, paramedical clinicians, and so forth, though truly, this work was typically Larina Brooklyn done by the establishing strict orders or by volunteers. College of Medicine and Health Academy, Nigeria Medical Care Community E-mail: [email protected] Medical care habitats, including facilities, specialist's workplaces, earnest consideration communities and mobile medical procedure places, Copyright: © 2021 Larina Brooklyn . This is an open-access article distributed fill in as first resource with a health proficient and give outpatient clinical, under the terms of the Creative Commons Attribution License, which permits nursing, dental, and different sorts of care administrations. unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Clinical Nursing Homes Clinical nursing homes, including private therapy places and geriatric Received 18 May 2021; Accepted 20 May 2021; Published 27 May 2021 consideration offices, are medical services foundations which have convenience offices and which take part in giving present moment or long haul clinical therapy of a general or concentrated nature not performed by clinics to inpatients with any of a wide assortment of ailments Introduction Drug Stores and Pharmacies A health facility is, by and large, any area where medical services is Drug stores and pharmacies involve foundations occupied with given. Health offices range from little facilities and specialist's workplaces retailing remedy or nonprescription medications and prescriptions, to dire consideration places and enormous medical clinics with intricate and different kinds of clinical and muscular goods.[4] Regulated drug trauma centers and emergency rooms. -
Operational Considerations for Case Management of COVID-19 in Health Facility and Community Interim Guidance 19 March 2020
Operational considerations for case management of COVID-19 in health facility and community Interim guidance 19 March 2020 Background This document is intended for health ministers, health system administrators, and other decision-makers. It is meant to guide the care of COVID-19 patients as the response capacity of health systems is challenged; to ensure that COVID-19 patients can access life-saving treatment, without compromising public health objectives and safety of health workers. It promotes two key messages: 1. Key public health interventions regardless of transmission scenario; and 2. Key action steps to be taken by transmission scenario to enable timely surge of clinical operations. The public health objectives at all stages of the preparedness and response plan are to: • Prevent outbreaks, delay spread, slow and stop transmission. • Provide optimized care for all patients, especially the seriously ill. • Minimize the impact of the epidemic on health systems, social services, and economic activity. Based on the largest cohort of COVID-19 patients, about 40% of patients with COVID-19 may have mild disease, where treatment is mostly symptomatic and does not require inpatient care; about 40% of patients have moderate disease that may require inpatient care; 15% of patients will have severe disease that requires oxygen therapy or other inpatient interventions; and about 5% have critical disease that requires mechanical ventilation.1 However, the evolution of the outbreak in some countries has shown a higher proportion of severe and critical cases and the need to rapidly increase surge capacity to prevent rapid exhaustion of biomedical supplies and staff. In some countries, doubling rates of cases every 3 days has been observed.2 Scenarios of transmission Countries or subnational areas will have to respond rapidly to one or more epidemiological scenarios. -
A Model Policy for SMART Health Facilities the Model Policy for SMART Health Facilities Was Prepared by Dr
A Model Policy for SMART Health Facilities The Model Policy for SMART Health Facilities was prepared by Dr. Vasantha Chase, et al, (Castries, Saint Lucia), on behalf of the Pan American Health Organization (2013). TABLE OF CONTENTS Foreword . 3 Section I – Defining the Problem . 5 • The vulnerability of health facilities to natural hazards . 5 • The vulnerability of health facilities to climate change and variability . 6 • Damage to health facilities from disasters . 7 • The cost of damage to health facilities in the Caribbean . 8 • Costs related to climate change and variability . 9 • Progress is being made . 10 Section II –Conceptual Framework for a Policy on SMART Health Facilities . 13 Section III – A Model for Developing a SMART Health Facilities Policy . 17 • Purpose of the policy . 17 • Policy guidelines . 17 • Components of the policy . 18 • Policy strategy . 21 • Implementing the policy . 22 • Monitoring, evaluation and reporting . 23 Conclusion . 25 Acronyms . 26 Glossary . 27 List of Tables • Table 1: Impact of Hurricane Tomas (2010) on health facilities in Saint Lucia . 7 • Table 2: Categorization of Energy Supply in Health Facilities in Guyana . 10 List of Figures • Figure 1: SMART Health Facilities Policy: The conceptual framework . 14 • Figure 2: Operationalising the SMART Health Facilities Policy . 16 • Figure 3: Mapping the Policy on SMART Health Facilities . 19 1 FOREWORD he Caribbean is a highly hazard-prone region. Hurricanes Gilbert, Ivan and Tomas are stark reminders of how the direct and indirect impact of weather-related disasters can significantly Tdisrupt access to health services and the sector’s ability to provide care. However, today it also is becoming increasingly clear that the health sector itself is one of many contributors to the impact of climate change, making it imperative to step up efforts to reduce the environmental footprint and increase the resiliency of its health facilities. -
A Thesis Entitled Quality of Life of People Who Stutter by Emily
A Thesis entitled Quality of Life of People who Stutter by Emily Figliomeni Submitted to the Graduate Faculty as partial fulfillment of the requirements for the Master of Arts Degree in Speech Language Pathology _________________________________________ Dr. Rodney Gabel, Ph.D., CCC-SLP, BCS-F, Committee Chair _________________________________________ Dr. Stephanie Hughes, Ph.D., CCC-SLP, Committee Member _________________________________________ Mrs. Jennifer Glassman, M.A. CCC-SLP, Committee Member _________________________________________ Dr. Patricia R. Komuniecki, Ph.D., Dean College of Graduate Studies The University of Toledo May 2015 Copyright 2015, Emily Figliomeni This document is copyrighted material. Under copyright law, no parts of this document may be reproduced without the expressed permission of the author. An Abstract of Quality of Life of People who Stutter by Emily Figliomeni Submitted to the Graduate Faculty as partial fulfillment of the requirements for the Master of Arts Degree in Speech Language Pathology The University of Toledo May 2015 Stuttering is a communication disorder that can impact a person’s life. The purpose of this study was to qualitatively explore the impact of stuttering on quality of life (QOL), and the differences between the beliefs of people who stutter (PWS) and the speech-language pathologist (SLP) regarding this issue. Individual experiences were obtained through the process of open-ended interviews with six PWS, and six SLPs who work with PWS. Major recurring themes included: 1) restriction, 2) identity, 3) positivity, 4) control, and 5) therapy impact. Similar beliefs were shared among individuals in both groups of participants, and were reflected in additional minor themes including therapy impact on QOL, physical impact, empowerment, acceptance, authenticity, and restriction regarding occupation and personal relationships. -
Body Substance Isolation PERSONAL PROTECTIVE
CACC Standard 6A Body Substance Isolation AND UNIVERSAL PRECAUTIONS TRAINING PERSONAL PROTECTIVE EQUIPMENT • Blocks entry of an organism into the body – Gloves are most common • Make sure all first aid kits contain several pairs of vinyl, laytex, or Nitrile gloves • Protective eyewear, standard surgical masks, and/or respirators may be necessary • Mouth to barrier (breathing masks) are also recommended PERSONAL PROTECTIVE EQUIPMENT (PPE) • No case of disease transmission to a rescuer as a result of performing unprotected CPR in an infected victim has been documented (only 15 cases of infection reported in last 30 years!) . However, mouth to barrier devices are still strongly recommended! 1 CACC Training Aid 39-H-7 Last Modified 10 Oct 07 CACC Standard 6A UNIVERSAL PRECAUTIONS • Individuals infected with Hepatitis B Virus (HBV) or HIV may not show symptoms and may not even know they are infectious. • All human blood and body fluids should be considered infectious, and precautions should be taken to avoid contact. UNIVERSAL PRECAUTIONS • The Body Substance Isolation (BSI) technique assumes that all body fluids are a potential risk. • Follow BSI procedures even when blood and/or body fluids are not visible UNIVERSAL PRECAUTIONS • Wear appropriate PPE, such as gloves • Use absorbent barriers to soak up blood or other infectious materials • Clean the spill area with an appropriate disinfecting solution, such as bleach • Discard contaminated materials in an appropriate waste disposal container 2 CACC Training Aid 39-H-7 Last Modified 10 Oct -
The Revised CDC Guidelines for Isolation Precautions in Hospitals: Implications for Pediatrics
AMERICAN ACADEMY OF PEDIATRICS Committee on Infectious Diseases and Committee on Hospital Care The Revised CDC Guidelines for Isolation Precautions in Hospitals: Implications for Pediatrics ABSTRACT. The Hospital Infection Control Practices timal performance of an expanded set of universal Advisory Committee of the US Centers for Disease Con- precautions, now called standard precautions, for the trol and Prevention and the National Center for Infec- care of all patients regardless of their diagnosis or tious Diseases have issued new isolation guidelines that presumed infection status, and pathogen and syn- replace earlier recommendations. Modifications of these drome-based precautions, termed transmission- guidelines for the care of hospitalized infants and chil- based precautions, for the care of patients who are dren should be considered specifically as they relate to glove use for routine diaper changing, private room iso- infected or colonized with pathogens spread through lation, and common use areas such as playrooms and airborne, droplet, or contact routes. schoolrooms. These new guidelines replace those pro- vided in the 1994 Red Book and have been incorporated STANDARD PRECAUTIONS into the 1997 Red Book. Standard precautions now apply to nonintact skin, mucous membranes, blood, all body fluids, secre- ABBREVIATION. CDC, Centers for Disease Control and Preven- tions, and excretions except sweat, regardless of tion. whether or not they contain visible blood. These general methods of infection prevention are indi- hese new isolation guidelines developed by the cated for all patients and are designed to reduce the Hospital Infection Control Practices Advisory risk of transmission of microorganisms from both Committee of the US Centers for Disease Con- recognized and unrecognized sources of infection in T hospitals. -
Sound Ethics in Health Care in Depth: Speak Up! Listen Up! May 14, 2018
Sound Ethics in Health Care In Depth: Speak Up! Listen Up! May 14, 2018 Dr. John Billig: Hello, and thank you for joining today's IntegratedEthics Improvement Forum Call. I'm John Billig, Chief of IntegratedEthics. As you probably know, today marks the beginning of National Compliance and Ethics Week in VA. This year's theme is Speak up! Listen up! And today's call will celebrate that theme. It promises to be an interesting and enlightening discussion. And now to kick things off, it's my great pleasure today to introduce our first speaker, Dr. Gerard Cox. Dr. Cox is Acting Deputy Under Secretary for Health for Organizational Excellence while continuing to serve as Assistant Deputy Under Secretary for Health for Integrity. Prior to his current role, he served as Assistant Deputy Under Secretary for Health for Policy and Services, Interim Medical Inspector, and Assistant Deputy Under Secretary for Health for Integrity. Before joining VA in 2014, Dr. Cox spent more than 30 years in military medicine. As a U.S. Navy medical officer, he served in a series of hospital leadership roles with increasingly complex management responsibilities, including service chief, service line leader, chief operating officer, and chief executive officer. He also held executive positions with the Navy Surgeon General, the commandant of the Marine Corps, the commander of U.S. Navy forces in the Middle East, and the Naval Inspector General. In addition, Dr. Cox served as a White House physician for Presidents William J. Clinton and George W. Bush. Dr. Cox, thank you for joining us today.